News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...


  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

Recent Postings



Galena (GALE) Sanofi-Aventis (SAN) Elan (ELN) Array Pharmaceuticals (ARRY) Revlimid (lenolidamide) Spike Therapeutics (ONCE) CRISPR Therapeutics (CRSP) Valeant Pharmaceuticals International (VRX) Theravance (THRX) JUNO (JUNO) Human Genome Sciences (HGSI) Sarepta (SRPT) RenenxBio (RGNX) KITE (KITE) Incyte (INCY) Roche (RHHBY) Endometrial Cancer Dynavax (DVAX) AGOS (ARGS) Merck (MRK) OSI (OSIP) AERIE PHARMACEUTICALS Gilead (GILD) Theravance Bio Pharma (TBPH) GUARDIAN HEALTH Cytokinetics (CYTK) Exelixis (EXEL) Ridaforolimus Roche (ROCHE) Alnylam (ALNY) Ziofpharm (ZIOP) Illumina (ILMN) ARGOS (ARGS) Bellicum (BLCM) Abbott Laboratories (ABT) Ariad (ARIA) Sequenom (SQNM) CompuGen (CGEN) Sanofi (SNY) Tysabri ADVENTRIX (ANX) Mirati Therapeutics (MRTX) Editas (EDIT) Seattle Genetics (SGEN) GlaxoSmithKline (GSK) NEKTAR (NKTR)) Anacor (ANAC) Adaptimmune (ADAP) Biogen Idec (BIIB) Agenus (AGEN JOUNCE THERAPEUTICS (JNCE) Idenix (IDIX) Herceptin HALOZYME (HALO) ABBVIE (ABBV) Ocular Therapeutix (OCUL) Sangamo (SGMO) Prolor Biotech (PBTH) Sanofi (SNA) OncoCyte (OCX) SERES THERAPEUTICS (MCRB) ZALTRAP™ PORTOLA (PTLA) Agenus (AGEN) Rapamune LEXICON (LXRX) TOKAI (TKAOI) IDERA (IDRA) galapagos (GLPG) MODERNA Dendreon (DNDN) Velcade (bortezomib) Pluristem (PSTI) INNOVIVA (INVA) ISIS (ISIS) Ionis (IONS) NANTKWEST (NK) Prosensa (RNA) Auspex (ASPX) ACADIA (ACAD) ARCA (ABIO) Amgen (AMGN) Bristol-Myers Squibb (BMY) Vertex (VRTX) Alder Biopharmaceuticals (ALDR) Multiple Myeloma PTC Therapeutics (PTCT) Aimmune Therapeutics (AIMT) SYNTA (SNTA) NEUROCRINE (NBIX) Biocryst (BCRX) Zerenex Intrexon (XON) Human Longevity (HLI) Telaprevir Onyx (ONXX) Global Cell Therapeutics (GBT) VANDA (VNDA) ImmunoGen (IMGN) Inovio (INO) Anadys (ANDS) KERYX (KERX) Intermune (ITMN) Xoma (XOMA) Jazz Pharmaceuticals (JAZZ) Intercept (ICPT) C4 Therapeutics Vitae Pharmaceuticals (VTAE) AstraZeneca (AZN) Benlysta (belimumab) SUNESIS PHARMACEUTICALS (SNSS) Trastuzumab-DM1 CEMPRA (CEMP) NOVOCURE (NVCR) REGULUS (RGLS) Micromet (MITI) Advaxis (ADXS) Genentech Regeneron (REGN) BIOMARIN (BMRN)